Case Report Pityriasis Versicolor Resistant to Antifungal Drugs in a Patient in Lom´e (Togo)
暂无分享,去创建一个
B. Saka | P. Pitché | J. Teclessou | S. Akakpo | K. Kombaté
[1] I. Maatouk,et al. Pityriasis versicolor: a case of resistance to treatment , 2014, International journal of dermatology.
[2] P. Vandeputte,et al. Antifungal Resistance and New Strategies to Control Fungal Infections , 2011, International journal of microbiology.
[3] M. Bigby,et al. Pityriasis versicolor: a systematic review of interventions. , 2010, Archives of dermatology.
[4] R. Schwartz,et al. Superficial fungal infections , 2004, The Lancet.
[5] R. Summerbell,et al. Pityriasis versicolor , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.
[6] O. Köse,et al. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor , 2002, The Journal of dermatological treatment.
[7] A. Rubin,et al. Six Novel Antimycotics , 2002, American journal of clinical dermatology.
[8] F. Montero‐Gei,et al. Fluconazole vs. Itraconazole in the treatment of tinea versicolor , 1999, International journal of dermatology.
[9] H. Trau,et al. Itraconazole versus ketoconazole in the treatment of tinea versicolor , 1999 .
[10] M. Mokni,et al. [Ketoconazole foaming gel in tinea versicolor (report of 60 cases)]. , 1999, La Tunisie medicale.
[11] N. Zaias. Pityriasis versicolor with ketoconazole. , 1989, Journal of the American Academy of Dermatology.